Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | VERU-100 |
Synonyms | |
Therapy Description |
VERU-100 is a GnRH antagonist, which suppresses testosterone levels (Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020) 128-128). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
VERU-100 | VERU100|VERU 100 | VERU-100 is a GnRH antagonist, which suppresses testosterone levels (Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020) 128-128). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04843319 | Phase Ib/II | VERU-100 | To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (VERU-100) | Terminated | USA | 0 |